Merck Serono International S.A.

Q1 2008

Publication of Merck Group business results for 1st quarter of 2008:

Total revenues for the Merck Serono division up by 9.7%

In the News

May 5, 2008Unique Three-Year Data Demonstrating Long-Term Efficacy and Safety of Raptiva® in the Treatment of Psoriasis Published in the British Journal of Dermatology

Fast Facts

euros invested annually to discover and develop new therapies

Welcome to Merck Serono

Welcome to the Merck Serono International S.A. website

Merck Serono is the division for innovative small molecules and biopharmaceuticals of Merck KGaA.

Merck Serono’s global headquarters are located in Geneva, Switzerland. In the United States and Canada, the division operates as EMD Serono.

Copyright© 2007-2008 Merck Serono International S.A.
Merck Serono is a division of Merck KGaA in Darmstadt, Germany.
Residents of the United States should consult the EMD Serono, Inc.
website for information on products and services approved in the US.

Last updated: 05/05/2008Legal Statement